Citing significant, unresolved safety risks, a total lack of robust human clinical efficacy data, and grave concerns over immunogenicity and peptide-related impurities, the FDA officially designated 19 of the most popular therapeutic peptidesexplicitly including BPC-157, TB-500 (Thymosin beta-4 fragment), and injectable GHK-Cuas Category 2 bulk drug substances
Pharmaceuticals (Basel) 17(2):147
Following multiple presentations of CJC-1295, mean IGF-I levels appear to stay above baseline for up to 28 days
The brightening is real my skin looks fresher even before I apply anything else
Azo dyes in the food industry: Features, classification, toxicity, alternatives, and regulation